Methods for treating benign prostatic hyperplasia using tocotrienols
US6187811A · kind A · utility
18Cited by
11References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 28, 1998 |
| Grant date | Feb 13, 2001 |
| Priority date | — |
| Expiry date | Oct 28, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to the treatment of benign prostatic hyperplasia (BPH) using tocotrienols. Specifically, this invention relates to compositions and the use of compositions comprising individual tocotrienols, mixtures of tocotrienols and mixtures of one or more tocotrienols with other anti-BPH substances.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.